DTL
BEAM icon

Dynamic Technology Lab’s Beam Therapeutics BEAM Stock Holding History

Dynamic Technology Lab’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,154
Closed -$292K – 829
2025
Q2 		$292K Buy
+17,154
New +$299K 0.04% 690
2024
Q2 		– Sell
-30,196
Closed -$998K – 957
2024
Q1 		$998K Buy
30,196
+13,132
+77% +$409K 0.11% 327
2023
Q4 		$464K Buy
+17,064
New +$424K 0.05% 621
2022
Q2 		– Sell
-17,370
Closed -$995K – 1137
2022
Q1 		$995K Buy
+17,370
New +$1.14M 0.12% 280
2021
Q4 		– Sell
-2,657
Closed -$231K – 1128
2021
Q3 		$231K Buy
2,657
+487
+22% +$48.9K 0.03% 857
2021
Q2 		$279K Sell
2,170
-1,554
-42% -$124K 0.03% 817
2021
Q1 		$298K Buy
+3,724
New +$354K 0.03% 796

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Dynamic Technology Lab's BEAM Position: Q3 2025 in Review

Dynamic Technology Lab sold out of Beam Therapeutics (BEAM) in Q3 2025, closing a stake of 17,154 shares — an estimated $292K sold.

Dynamic Technology Lab first reported a position in BEAM in Q1 2021 and held it in 7 quarters. The position peaked at $998K in Q1 2024. 219 funds tracked by Wall St. Rank hold BEAM as of Q3 2025.

  • Dynamic Technology Lab reported no remaining Beam Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 17,154 Beam Therapeutics shares in Q3 2025, an estimated $292K.
  • Dynamic Technology Lab first reported a position in Beam Therapeutics in Q1 2021 and held it in 7 quarters.
  • Dynamic Technology Lab's Beam Therapeutics position peaked at $998K in Q1 2024.
  • 219 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2025.

Based on Dynamic Technology Lab's 13F filing for Q3 2025, filed 13 Nov 2025.